Pharmacokinetics, Metabolism, and Saliva Output During Transdermal and Extended-Release Oral Oxybutynin Administration in Healthy Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics, Metabolism, and Saliva Output During Transdermal and Extended-Release Oral Oxybutynin Administration in Healthy Subjects

Published:2003-06 Issue:6 Volume:78 Page:696-702
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Appell Rodney A.,Chancellor Michael B.,Zobrist R. Howard,Thomas Heather,Sanders Steven W.

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Oxybutynin versus propantheline in the management of detrusor instability: a patient-regulated variable dose trial;Holmes;Br J Obstet Gynaecol,1989

2. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability;Moore;Br J Urol,1990

3. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study;Tapp;Br J Obstet Gynaecol,1990

4. Randomized, double-blind, multicenter trial on treatment of frequency, urgency, and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo;Thuroff;J Urol,1991

5. Oxybutynin chloride in the treatment of female idiopathic bladder instability: results from double blind treatment;Riva;Clin Exp Obstet Gynecol,1984

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin;Acta Neuropathologica;2024-03-25

2. First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring;Drug Delivery;2023-02-22

3. Drug Treatment;Handbook of Neurourology;2023

4. Drug Treatment;Handbook of Neurourology;2023

5. A Population Pharmacokinetic Model of (R)‐ and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy Volunteers;The Journal of Clinical Pharmacology;2021-01-13